C. Yoshikumi

发表

Influence of PSK (Krestin) on resistance to infection ofPseudomonas aeruginosa in tumor-bearing mice

T. Ando, K. Nomoto, I. Motokawa, 2004, Cancer Chemotherapy and Pharmacology.

Effect of PSK, a protein-bound polysaccharide from Coriolus versicolor, on drug-metabolizing enzymes in sarcoma-180 bearing and normal mice.

Y. Kawai, S. Muto, H. Fujita, 1988, International journal of immunopharmacology.

Purification and characterization of immunosuppressive (IS) substance obtained from ascitic fluids of patients with gastrointestinal cancer.

K. Matsunaga, C. Yoshikumi, M. Fujii, 1987, Clinical biochemistry.

Tumor growth-promoting effect of immunosuppressive substance in mice.

Y. Omura, T. Fujii, K. Matsunaga, 1989, Cancer investigation.

Restoration of immune responsiveness by a biological response modifier, PSK, in aged mice bearing syngeneic transplantable tumor.

K. Nomoto, T. Fujii, K. Matsunaga, 1987, Journal of clinical & laboratory immunology.

Tumor growth promoting activity of an immunosuppressive substance and its modulation by protein-bound polysaccharide PSK.

Y. Kawai, K. Saito, T. Fujii, 1987, Immunology letters.

Restoration of antibody-forming capacities by PS-K in tumor-bearing mice.

K. Nomoto, K. Takeya, T. Fujii, 1975, Gan.

Comparative study of alpha 1-acid glycoprotein molecular variants in ascitic fluid of cancer and non-cancer patients.

K. Matsunaga, C. Yoshikumi, M. Fujii, 1988, Anticancer research.

Effect of PSK on cytotoxicity against sarcoma-180 in tumor-bearing mice.

T. Ando, K. Nomoto, T. Fujii, 1987, Anticancer research.

Cloning of sequences induced and suppressed by administration of PSK, antitumor protein-bound polysaccharide.

K. Hirose, M. Hakozaki, H. Endo, 1985, Biochemical and biophysical research communications.

Production of antiserum against antitumor protein-bound polysaccharide preparation, PSK (Krestin) and its pharmacological application.

T. Suzuki, Y. Kawai, K. Nomoto, 1988, International journal of immunopharmacology.

Evaluation of anticancer drugs by lymphocyte electrophoresis.

N. Toyama, Y. Kawai, T. Fujii, 1986, Journal of pharmacobio-dynamics.

[Effect of PSK on the recovery of macrophage function in tumor-bearing mice].

T. Ando, K. Nomoto, T. Fujii, 1984, Gan to kagaku ryoho. Cancer & chemotherapy.

Mouse strain difference in the expression of antitumor activity of PS-K.

K. Nomoto, K. Takeya, T. Fuji, 1975, Gan.

Measurement of Mixed Cell Populations by an Automated Cell Electrophoretic Instrument

N. Toyama, K. Matsunaga, C. Yoshikumi, 1984 .

Effect of a biological response modifier, PSK, on intestinal flora of tumor-bearing mice.

T. Ando, K. Nomoto, K. Saito, 1993, In vivo.

Animal Pharmacological Effects of 24R,25-Dihydroxyvitamin D3 One of the Endogenous Substances Regulating Calcium Metabolism

Y. Kawai, H. Iijima, K. Nomoto, 1988, The Journal of international medical research.

Antibody against the human bladder cancer

Kenichi Saito, T. Fujii, K. Matsunaga, 1984 .

Specific regulation of HSPs in human tumor cell lines by flavonoids.

K. Matsunaga, C. Yoshikumi, N. Saijo, 1997, In vivo.

Specific expression of HSP27 in human tumor cell lines in vitro.

K. Matsunaga, C. Yoshikumi, N. Saijo, 1997, In vivo.

Competitive action of a biological response modifier, PSK, on a humoral immunosuppressive factor produced in tumor-bearing hosts.

H. Iijima, K. Nomoto, H. Endo, 1990, Journal of clinical & laboratory immunology.

Mechanism of Action of the Antitumour Effect of K18

H. Iijima, K. Saito, Y. Kobayashi, 1989, The Journal of international medical research.

Tumor and tissue distribution of 125I-labeled natural and antitumor antibodies in murine experimental tumor systems.

Y. Kawai, T. Fujii, K. Matsunaga, 1988, Anticancer Research.

In vivo antineoplastic activity of mouse or human IgG conjugated with melphalan.

Y. Kawai, T. Fujii, K. Matsunaga, 1987, In Vivo.

[Restoration of immunologic responsiveness by PSK in tumor-bearing animals].

K. Nomoto, T. Fujii, K. Matsunaga, 1986, Gan to kagaku ryoho. Cancer & chemotherapy.

Decreased expression of HSP47 in highly malignant mouse fibrosarcoma.

F. Okada, M. Hosokawa, C. Yoshikumi, 1995, In Vivo.

Specific expression of HSP47 in human tumor cell lines in vitro.

K. Matsunaga, C. Yoshikumi, N. Saijo, 1997, In vivo.

Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.

H. Iijima, K. Nomoto, T. Fujii, 1992, Journal of clinical & laboratory immunology.

Enhancement of the antitumor effect by the concurrent use of a monoclonal antibody and the protein-bound polysaccharide PSK in mice bearing a human cancer cell line.

N. Taniguchi, Kenichi Saito, H. Endoh, 1994, In Vivo.

Determination of cell mixtures by an automated cell electrophoretic instrument and monoclonal antibody

N. Toyama, Y. Kawai, C. Yoshikumi, 1987 .